Vigil Neuroscience Ownership | Who Owns Vigil Neuroscience?


OverviewForecastRevenueFinancialsChart

Vigil Neuroscience Ownership Summary


Vigil Neuroscience is owned by 68.33% institutional investors, 21.27% insiders, and 10.40% retail investors. Atlas venture life science advisors is the largest institutional shareholder, holding 14.64% of VIGL shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.74% of its assets in Vigil Neuroscience shares.

VIGL Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVigil Neuroscience68.33%21.27%10.40%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Atlas venture life science advisors5.84M14.64%$23.35M
Northpond ventures4.21M10.57%$16.86M
Artal group1.83M4.59%$7.31M
Bvf inc/il1.81M4.55%$7.25M
Sphera funds management1.69M4.24%$6.77M
Point72 asset management1.49M3.73%$5.94M
Citadel advisors1.44M3.62%$5.77M
683 capital management1.10M2.76%$4.40M
Vanguard group814.73K2.04%$3.26M
Stempoint capital lp744.41K1.87%$2.98M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Northpond ventures4.21M30.50%$16.86M
Atlas venture life science advisors5.84M2.46%$23.35M
Pivotal bioventure partners investment advisor560.60K1.72%$2.24M
Sphera funds management1.69M0.92%$6.77M
Stempoint capital lp744.41K0.88%$2.98M
683 capital management1.10M0.33%$4.40M
Bvf inc/il1.81M0.20%$7.25M
Artal group1.83M0.19%$7.31M
Deep track capital, lp597.22K0.07%$2.39M
Rock springs capital management lp471.96K0.06%$1.89M

Top Buyers

HolderShares% AssetsChange
Point72 asset management1.49M0.02%1.49M
Stempoint capital lp744.41K0.88%744.41K
Goldman sachs group401.14K0.00%382.90K
Millennium management334.81K0.00%301.68K
Woodline partners lp206.61K0.01%206.61K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp597.22K0.07%-997.72K
Deerfield management company, l.p. (series c)---980.31K
Citadel advisors1.44M0.00%-722.65K
Blackrock405.04K--471.99K
State street40.74K--245.32K

New Positions

HolderShares% AssetsChangeValue
Point72 asset management1.49M0.02%1.49M$5.94M
Stempoint capital lp744.41K0.88%744.41K$2.98M
Woodline partners lp206.61K0.01%206.61K$826.46K
Susquehanna group, llp48.05K-48.05K$192.20K
Qube research30.43K0.00%30.43K$121.72K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-2.00
New york state common retirement fund-140.00
Amalgamated bank-542.00
Ameritas investment partners-1.33K
Legal & general group-1.55K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202452-7.14%27,725,2116.11%681.59%24-22.58%185.88%
Jun 30, 2024567.69%26,129,244-1.47%651.40%3155.00%1713.33%
Mar 31, 20245213.04%26,518,6766.23%681.66%20-9.09%1525.00%
Dec 31, 2023462.22%24,962,629-2.27%641.47%2237.50%12-
Sep 30, 202345-4.26%25,543,602-0.81%661.48%16-40.74%1250.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv710.14K1.74%-
abrdn Life Sciences Investors235.01K0.57%-
BlackRock Health Sciences Term Trust215.43K0.54%8.07K
Vanguard Institutional Extnd Mkt Idx Tr170.24K0.42%-
Fidelity Extended Market Index116.88K0.29%35.79K
Bridgeway Ultra-Small Company Market97.16K0.24%25.00K
NT R2000 Value Index Fund - NL42.43K0.11%-6.83K
NT R2000 Index Fund - NL40.34K0.10%-1.64K
iShares Micro-Cap ETF39.39K0.10%-
Fidelity Total Market Index37.90K0.10%10.10K

Recent Insider Transactions


DateNameRoleActivityValue
Dec 19, 2024Budd Haeberlein Samantha L.-Buy$20.52K
Dec 19, 2024Magovcevic-Liebisch Ivana President and CEOBuy$8.40K
Dec 18, 2024Magovcevic-Liebisch Ivana President and CEOBuy$8.35K
Dec 05, 2024Magovcevic-Liebisch Ivana President and CEOBuy$11.70K
Nov 20, 2023Magovcevic-Liebisch Ivana President and CEOBuy$15.00K

Insider Transactions Trends


DateBuySell
2024 Q44-
2024 Q2--
2024 Q1--
2023 Q41-
2023 Q3--

VIGL Ownership FAQ


Who Owns Vigil Neuroscience?

Vigil Neuroscience shareholders are primarily institutional investors at 68.33%, followed by 21.27% insiders and 10.40% retail investors. The average institutional ownership in Vigil Neuroscience's industry, Biotech Stocks , is 47.04%, which Vigil Neuroscience exceeds.

Who owns the most shares of Vigil Neuroscience?

Vigil Neuroscience’s largest shareholders are Atlas venture life science advisors (5.84M shares, 14.64%), Northpond ventures (4.21M shares, 10.57%), and Artal group (1.83M shares, 4.59%). Together, they hold 29.80% of Vigil Neuroscience’s total shares outstanding.

Does Blackrock own Vigil Neuroscience?

BlackRock is not among the top 10 institutional shareholders of Vigil Neuroscience.

Who is Vigil Neuroscience’s biggest shareholder by percentage of total assets invested?

Northpond ventures is Vigil Neuroscience’s biggest shareholder by percentage of total assets invested, with 30.50% of its assets in 4.21M Vigil Neuroscience shares, valued at 16.86M$.

Who is the top mutual fund holder of Vigil Neuroscience shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Vigil Neuroscience shares, with 1.74% of its total shares outstanding invested in 710.14K Vigil Neuroscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools